Work

Phase I clinical trial to assess the safety of pNGVL4aCRTE6E7L2 DNA and TA-CIN protein vaccinations and to seek the appropriate dose of the pNGVL4aCRTE6E7L2 DNA vaccine

Year: 2024

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2024.07.439

Authors: Kimberly Levinson, Rebecca Arend, Richard Roden, T.C. Wu, Darin Ostrander, Karen Horner, Sellers Swann, Peter Ketch, Zachary Gentry, Alfonsus Adrian Harsono, Fibiana Oladipo, Stephanie Clevenger, Anna Wilbanks, Wade Barton, Lia Bos, Chien-Fu Hung, Charles Leath, Warner Huh

Institutions: Johns Hopkins University, University of Alabama at Birmingham

Language: English

Topic: Cervical Cancer and HPV Research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403251220

FWCI:

Cites:

Cited by:

Related to: 10